NeuroXT Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Early Stage VC
- Investors
-
13
NeuroXT General Information
Description
Developer of precision diagnosis software intended to predict molecular pathology values. The company uses magnetic resonance imaging (MRI) images to analyze a specific treatment drug's effects or side effects on the patient to determine suitability, enabling the healthcare sector to benefit from precision treatment for degenerative brain diseases based on various image analysis experiences.
Contact Information
Website
www.neuroxt.comCorporate Office
- Seongsu SK V1 Center, Building 1, Room 601
- 48, Achasan-ro 17-gil, Seongdong-gu
- Seoul, 04799
- South Korea
Corporate Office
- Seongsu SK V1 Center, Building 1, Room 601
- 48, Achasan-ro 17-gil, Seongdong-gu
- Seoul, 04799
- South Korea
NeuroXT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 09-Mar-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 01-Dec-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jul-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jun-2022 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroXT Signals
NeuroXT Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LG | Holding Company | Minority | ||
| Medinno Partners | Venture Capital | Minority | ||
| Samsung Venture Investment | Corporate Venture Capital | Minority | ||
| KU Startup | Accelerator/Incubator | |||
| DAYLI Partners | Venture Capital | Minority |
NeuroXT FAQs
-
When was NeuroXT founded?
NeuroXT was founded in 2022.
-
Where is NeuroXT headquartered?
NeuroXT is headquartered in Seoul, South Korea.
-
What is the size of NeuroXT?
NeuroXT has 22 total employees.
-
What industry is NeuroXT in?
NeuroXT’s primary industry is Decision/Risk Analysis.
-
Is NeuroXT a private or public company?
NeuroXT is a Private company.
-
What is NeuroXT’s current revenue?
The current revenue for NeuroXT is .
-
Who are NeuroXT’s investors?
LG, Medinno Partners, Samsung Venture Investment, KU Startup, and DAYLI Partners are 5 of 13 investors who have invested in NeuroXT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process